There were 1,481 clinical trials ongoing or completed in China during January 2010.

Outsourcing of pharmaceutical companies activities is on the rise among Asian countries such as China.

Clinical trial industry has been constantly expanding since 2000, and this has become one of the economic drivers in this country.

This report provides key information on how to conduct clinical trial in China, including:

• Chinese market dynamics

• Regulatory environment and key regulatory changes, procedures

• Clinical study design and planning,

• Market drivers and market barriers of conducting clinical trials in China

• Main actors of the market (including identification sheets of main CROs operating in China now).

Universal Medica, settled in China since 2005, has built a strong expertise of the Chinese healthcare market through dynamic market information selecting and analysing.

Download the brochure/order form